The TGA is updating the Evidence Guidelines for Listed Medicines in two phases in 2019:

Phase 1: An administrative update (newly released today) to reflect permitted indications.

Phase 2: Review of the guidelines to increase clarity (but not change the levels and kinds of evidence), with public consultation in 2019.

More information here.